Research Paper Volume 15, Issue 19 pp 10305—10329

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy


Figure 9. Mutation analysis. (A) Mutation landscape of the top 20 genes with mutation frequency in the high-low risk group. (B) TMB differences between high- and low-risk patients. (C) Relationship between risk score and tumor mutation burden. (D) Survival analysis between four different groups (High-TMB+High-Risk, High-TMB+Low-Risk, Low-TMB+High-risk, and Low-TMB+low-risk).